<DOC>
	<DOC>NCT00918814</DOC>
	<brief_summary>Dose Ranging and Dose Frequency of LIPO-102</brief_summary>
	<brief_title>Dose Ranging and Dose Frequency of LIPO-102</brief_title>
	<detailed_description />
	<criteria>Male or non pregnant female Good general health Sufficient abdominal fat for injections Signed informed consent Known hypersensitivity to study drugs Treatment with an investigational agent within 30 days of first dose</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>February 2015</verification_date>
</DOC>